Marker Therapeutics, Inc. (MRKR)

2.10 +0.06 (+2.94%) USD  |  NASDAQ  |  Jan 23, 16:00
2.09 -0.01 (-0.48%) Pre-Market: 20:00
More

Marker Therapeutics Market Cap Per Employee (Annual)

Market Cap Per Employee (Annual) Chart

View Market Cap Per Employee (Annual) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Market Cap Per Employee (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Market Cap Per Employee (Annual) Range, Past 5 Years

View Market Cap Per Employee (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Market Cap Per Employee (Annual) Benchmarks

View Market Cap Per Employee (Annual) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade